Cornerstone Planning Group LLC Harmony Biosciences Holdings, Inc. Transaction History
Cornerstone Planning Group LLC
- $407 Billion
- Q4 2024
A detailed history of Cornerstone Planning Group LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 11 shares of HRMY stock, worth $370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11Holding current value
$370% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$223 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$197 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$160 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$76.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$53.3 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.99B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...